JP2018164789A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018164789A5 JP2018164789A5 JP2018145202A JP2018145202A JP2018164789A5 JP 2018164789 A5 JP2018164789 A5 JP 2018164789A5 JP 2018145202 A JP2018145202 A JP 2018145202A JP 2018145202 A JP2018145202 A JP 2018145202A JP 2018164789 A5 JP2018164789 A5 JP 2018164789A5
- Authority
- JP
- Japan
- Prior art keywords
- tropoelastin
- wound
- tropoelastin composition
- composition according
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102100033167 Elastin Human genes 0.000 claims 34
- 108010014258 Elastin Proteins 0.000 claims 34
- 206010052428 Wound Diseases 0.000 claims 22
- 208000027418 Wounds and injury Diseases 0.000 claims 22
- 231100000241 scar Toxicity 0.000 claims 7
- 239000007790 solid phase Substances 0.000 claims 4
- 230000032683 aging Effects 0.000 claims 2
- 238000013532 laser treatment Methods 0.000 claims 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 239000004067 bulking agent Substances 0.000 claims 1
- 210000001339 epidermal cell Anatomy 0.000 claims 1
- 229920002674 hyaluronan Polymers 0.000 claims 1
- 229960003160 hyaluronic acid Drugs 0.000 claims 1
- 230000002459 sustained effect Effects 0.000 claims 1
- 238000013268 sustained release Methods 0.000 claims 1
- 239000012730 sustained-release form Substances 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019232193A JP6891257B2 (ja) | 2013-08-13 | 2019-12-24 | 損傷組織の再生 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2013903092 | 2013-08-13 | ||
| AU2013903092A AU2013903092A0 (en) | 2013-08-13 | Regeneration of damaged tissue |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016533753A Division JP6382311B2 (ja) | 2013-08-13 | 2014-08-13 | 損傷組織の再生 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019232193A Division JP6891257B2 (ja) | 2013-08-13 | 2019-12-24 | 損傷組織の再生 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018164789A JP2018164789A (ja) | 2018-10-25 |
| JP2018164789A5 true JP2018164789A5 (enExample) | 2018-12-06 |
| JP6639587B2 JP6639587B2 (ja) | 2020-02-05 |
Family
ID=52467858
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016533753A Active JP6382311B2 (ja) | 2013-08-13 | 2014-08-13 | 損傷組織の再生 |
| JP2018145202A Active JP6639587B2 (ja) | 2013-08-13 | 2018-08-01 | 損傷組織の再生 |
| JP2019232193A Active JP6891257B2 (ja) | 2013-08-13 | 2019-12-24 | 損傷組織の再生 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016533753A Active JP6382311B2 (ja) | 2013-08-13 | 2014-08-13 | 損傷組織の再生 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019232193A Active JP6891257B2 (ja) | 2013-08-13 | 2019-12-24 | 損傷組織の再生 |
Country Status (12)
| Country | Link |
|---|---|
| US (4) | US20160194379A1 (enExample) |
| EP (2) | EP4316537A3 (enExample) |
| JP (3) | JP6382311B2 (enExample) |
| KR (3) | KR20230004965A (enExample) |
| CN (2) | CN110464837A (enExample) |
| AU (3) | AU2014306362B2 (enExample) |
| BR (1) | BR112016003082A8 (enExample) |
| CA (1) | CA2920312C (enExample) |
| ES (1) | ES2965893T3 (enExample) |
| MX (2) | MX377200B (enExample) |
| RU (1) | RU2677637C2 (enExample) |
| WO (1) | WO2015021508A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9688741B2 (en) | 2012-10-23 | 2017-06-27 | Elastagen Pty Ltd | Elastic hydrogel |
| ES2860023T3 (es) | 2012-12-10 | 2021-10-04 | Allergan Pharmaceuticals Int Ltd | Fabricación de constructos elásticos tridimensionales escalables |
| EP4316537A3 (en) * | 2013-08-13 | 2024-04-10 | Allergan Pharmaceuticals International Limited | Regeneration of damaged tissue |
| WO2017035595A1 (en) * | 2015-09-01 | 2017-03-09 | Elastagen Pty Ltd | Formation of bone |
| EP3534982A4 (en) * | 2016-11-04 | 2020-06-10 | Allergan Pharmaceuticals International Limited | BIOSYNTHETIC DEVICES |
| US20200345623A1 (en) * | 2019-05-03 | 2020-11-05 | Allergan Pharmaceuticals International Limited | Methods of scar prevention and/or treatment |
| US20230310552A1 (en) * | 2020-09-08 | 2023-10-05 | Protein Genomics Inc. | Biomimetic wound healing devices and related methods of treating diabetic wounds |
Family Cites Families (65)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4675387A (en) | 1985-07-26 | 1987-06-23 | E. I. Du Pont De Nemours And Company | Method for extracting protein with organic acid |
| US5260203A (en) | 1986-09-02 | 1993-11-09 | Enzon, Inc. | Single polypeptide chain binding molecules |
| US4947840A (en) | 1987-08-21 | 1990-08-14 | Massachusetts Institute Of Technology | Biodegradable templates for the regeneration of tissues |
| ES2052027T5 (es) | 1988-11-11 | 2005-04-16 | Medical Research Council | Clonacion de secuencias de dominio variable de inmunoglobulina. |
| WO1991015502A1 (fr) | 1990-03-30 | 1991-10-17 | Shiseido Company, Ltd. | Procede de purification de polypeptide |
| EP0672068A4 (en) | 1992-09-25 | 1997-02-26 | Commw Scient Ind Res Org | TARGET MOLECULES BINDING POLYPEPTIDES. |
| ATE412052T1 (de) * | 1992-12-22 | 2008-11-15 | Univ Sydney | Synthetische polynukleotide |
| US5726040A (en) | 1993-11-10 | 1998-03-10 | Ensley; Burt D. | Cosmetic compositions including tropoelastin isomorphs |
| US7001328B1 (en) | 1994-11-15 | 2006-02-21 | Kenton W. Gregory | Method for using tropoelastin and for producing tropoelastin biomaterials |
| AUPO591797A0 (en) | 1997-03-27 | 1997-04-24 | Commonwealth Scientific And Industrial Research Organisation | High avidity polyvalent and polyspecific reagents |
| AU728480B2 (en) | 1996-08-07 | 2001-01-11 | Hospital For Sick Children, The | Self-aligning peptides derived from elastin and other fibrous proteins |
| AUPO156596A0 (en) * | 1996-08-09 | 1996-09-05 | University Of Sydney, The | Synthetic polynucleotides |
| WO1998034563A1 (en) | 1997-02-07 | 1998-08-13 | Sisters Of Providence In Oregon | Method for using tropoelastin and for producing tropoelastin biomaterials |
| AUPO811797A0 (en) | 1997-07-18 | 1997-08-14 | University Of Sydney, The | Tropoelastin derivatives |
| WO1999011196A1 (en) | 1997-09-04 | 1999-03-11 | Point Biomedical Corporation | Injectable tissue reconstruction material |
| AUPP472398A0 (en) | 1998-07-17 | 1998-08-13 | University Of Sydney, The | Protease susceptibility II |
| US20030190669A1 (en) | 1998-12-30 | 2003-10-09 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| CA2383539C (en) * | 1999-05-28 | 2007-12-04 | Kenton W. Gregory | Methods for producing laminated elastin, elastin-based materials and tropoelastin products for repairing and/or replacing tissue |
| EP1229940B1 (en) | 1999-11-15 | 2014-05-14 | Piramal Healthcare (Canada) Limited | Temperature-controlled and ph-dependant self-gelling biopolymeric aqueous solution |
| US20050244393A1 (en) | 1999-12-22 | 2005-11-03 | Henogen S.A. | Sealant or tissue generating product |
| US6808707B2 (en) * | 2000-02-04 | 2004-10-26 | Matrix Design | Wound healing compositions and methods using tropoelastin and lysyl oxidase |
| US20040110439A1 (en) | 2001-04-20 | 2004-06-10 | Chaikof Elliot L | Native protein mimetic fibers, fiber networks and fabrics for medical use |
| DE60228573D1 (de) | 2001-05-30 | 2008-10-09 | Chisso Corp | Vernetztes elastin und verfahren zu deren herstellung |
| AU2002952492A0 (en) | 2002-11-06 | 2002-11-21 | Cbio Limited | Chaperonin 10 immunosuppression |
| US8383158B2 (en) | 2003-04-15 | 2013-02-26 | Abbott Cardiovascular Systems Inc. | Methods and compositions to treat myocardial conditions |
| US8038991B1 (en) | 2003-04-15 | 2011-10-18 | Abbott Cardiovascular Systems Inc. | High-viscosity hyaluronic acid compositions to treat myocardial conditions |
| FR2855969B1 (fr) | 2003-06-13 | 2012-11-30 | Coletica | Stimulation de l'activite d'une isoforme de lysyl oxydase pour lutter contre certaines pathologies dues a une elastogenese incomplete, absente ou desorganisee |
| FR2855968B1 (fr) | 2003-06-13 | 2012-11-30 | Coletica | Stimulation de la synthese et de l'activite d'une isoforme de la lysyl oxydase-like loxl pour stimuler la formation de fibres elastiques |
| US8226715B2 (en) | 2003-06-30 | 2012-07-24 | Depuy Mitek, Inc. | Scaffold for connective tissue repair |
| CA2562871C (en) | 2004-02-20 | 2014-06-10 | Human Matrix Sciences, Llc | Iron based compounds for elastogenesis and connective tissue treatment |
| US7192043B1 (en) | 2004-05-25 | 2007-03-20 | Mcluen Design, Inc. | Multi-terrain wheel chair |
| US7968085B2 (en) | 2004-07-05 | 2011-06-28 | Ascendis Pharma A/S | Hydrogel formulations |
| US20060062768A1 (en) | 2004-09-23 | 2006-03-23 | Olexander Hnojewyj | Biocompatible hydrogel compositions |
| JP4381448B2 (ja) | 2005-03-16 | 2009-12-09 | 富士通株式会社 | Ｉｐネットワークにおけるマルチキャストツリー監視方法およびシステム |
| US20100233783A1 (en) | 2005-03-24 | 2010-09-16 | Straumann Holding Ag | Novel method for protein purification |
| US8828433B2 (en) | 2005-04-19 | 2014-09-09 | Advanced Cardiovascular Systems, Inc. | Hydrogel bioscaffoldings and biomedical device coatings |
| KR100785378B1 (ko) | 2005-09-05 | 2007-12-14 | 주식회사 바이오레인 | 다층구조의 유착방지제 |
| CA2626637A1 (en) | 2005-10-19 | 2007-04-26 | Kenton W. Gregory | Method of using and producing tropoelastin and tropoelastin biomaterials |
| US7770126B2 (en) | 2006-02-10 | 2010-08-03 | Microsoft Corporation | Assisting user interface element use |
| US8518105B2 (en) | 2006-03-24 | 2013-08-27 | Abbott Cardiovascular System Inc. | Methods and apparatuses for coating a lesion |
| US20070237735A1 (en) | 2006-03-31 | 2007-10-11 | Laboratoires Dermo-Cosmetik Inc. | Anti-aging composition, kit and method of use |
| EP2656832B1 (en) * | 2006-05-11 | 2018-12-19 | Regenics AS | Compositions for use in wound healing |
| US20070287741A1 (en) | 2006-06-13 | 2007-12-13 | Uri Herzberg | Compositions and methods for preventing or reducing postoperative ileus and gastric stasis in mammals |
| US8846624B2 (en) | 2006-09-11 | 2014-09-30 | Emory University | Modified protein polymers |
| EP2117620A4 (en) | 2006-09-29 | 2010-12-01 | Martin Kean Chong Ng | PROTOELASTINE BIOMATERIALS FROM TROOELASTINE |
| BRPI0718615B8 (pt) * | 2006-11-13 | 2021-06-22 | Allergan Australia Pty Ltd | processo para produzir um material elástico a partir de tropoelastina e material elástico |
| US20090136438A1 (en) * | 2007-07-25 | 2009-05-28 | Dermaplus, Inc. | Photo-protective dermatological formulations and methods of using the same |
| WO2009018546A1 (en) | 2007-08-02 | 2009-02-05 | Medicis Pharmaceutical Corporation | Method of applying an injectable filler |
| FR2920968B1 (fr) | 2007-09-14 | 2009-11-13 | Oreal | Procede cosmetique de traitement esthetique et/ou reparateur de la peau |
| WO2009099570A2 (en) | 2008-02-01 | 2009-08-13 | Wake Forest University Health Sciences | Aligned scaffolding system for skeletal muscle regeneration |
| US8469961B2 (en) | 2008-03-05 | 2013-06-25 | Neville Alleyne | Methods and compositions for minimally invasive capsular augmentation of canine coxofemoral joints |
| US8940331B2 (en) | 2008-11-22 | 2015-01-27 | The Board Of Trustees Of The Leland Stanford Junior University | Hydrogels, methods of making hydrogels, methods of using hydrogels, and methods of isolating, trapping, attracting, and/or killing cancer cells |
| US8080265B2 (en) | 2009-02-20 | 2011-12-20 | Johnson & Johnson Consumer Companies, Inc. | Compositions and methods for treating signs of skin aging |
| DK2405936T3 (da) | 2009-03-10 | 2019-11-04 | Allergan Pharmaceuticals Int Ltd | Injicerbare biomaterialer |
| HUE030138T2 (en) | 2010-03-22 | 2017-04-28 | Allergan Inc | Polysaccharide and protein-polysaccharide cross-linked hydrogels for soft tissue augmentation |
| WO2011127478A1 (en) | 2010-04-09 | 2011-10-13 | Nanovasc, Inc. | Sleeve for graft and method |
| US8658711B2 (en) | 2010-09-29 | 2014-02-25 | Rutgers, The State University Of New Jersey | Process for the synthesis of methacrylate-derivatized type-1 collagen and derivatives thereof |
| CN107281549B (zh) | 2010-11-23 | 2021-10-15 | 爱力根制药国际有限公司 | 与多糖交联的蛋白质的制备和/或制剂 |
| GB201021438D0 (en) | 2010-12-16 | 2011-02-02 | Imp Innovations Ltd | Layered fibrous construct |
| US9114128B2 (en) | 2011-09-30 | 2015-08-25 | Protein Genomics, Inc. | Tropoelastins and uses thereof |
| HUE060291T2 (hu) | 2011-09-30 | 2023-02-28 | Allergan Pharmaceuticals Int Ltd | Rugalmas rost in vivo szintézise |
| US9688741B2 (en) * | 2012-10-23 | 2017-06-27 | Elastagen Pty Ltd | Elastic hydrogel |
| ES2860023T3 (es) | 2012-12-10 | 2021-10-04 | Allergan Pharmaceuticals Int Ltd | Fabricación de constructos elásticos tridimensionales escalables |
| EP4316537A3 (en) * | 2013-08-13 | 2024-04-10 | Allergan Pharmaceuticals International Limited | Regeneration of damaged tissue |
| EP3049427A4 (en) | 2013-09-24 | 2017-05-31 | Elastagen Pty Ltd | Method of extracting protein |
-
2014
- 2014-08-13 EP EP23206907.0A patent/EP4316537A3/en active Pending
- 2014-08-13 RU RU2016104618A patent/RU2677637C2/ru active
- 2014-08-13 WO PCT/AU2014/050180 patent/WO2015021508A1/en not_active Ceased
- 2014-08-13 US US14/911,401 patent/US20160194379A1/en not_active Abandoned
- 2014-08-13 EP EP14836821.0A patent/EP3033099B1/en active Active
- 2014-08-13 ES ES14836821T patent/ES2965893T3/es active Active
- 2014-08-13 CN CN201910782833.0A patent/CN110464837A/zh active Pending
- 2014-08-13 MX MX2016001436A patent/MX377200B/es active IP Right Grant
- 2014-08-13 BR BR112016003082A patent/BR112016003082A8/pt not_active Application Discontinuation
- 2014-08-13 KR KR1020227045816A patent/KR20230004965A/ko not_active Abandoned
- 2014-08-13 CA CA2920312A patent/CA2920312C/en active Active
- 2014-08-13 CN CN201480049722.4A patent/CN105530951B/zh active Active
- 2014-08-13 JP JP2016533753A patent/JP6382311B2/ja active Active
- 2014-08-13 KR KR1020217040694A patent/KR102488446B1/ko active Active
- 2014-08-13 AU AU2014306362A patent/AU2014306362B2/en active Active
- 2014-08-13 KR KR1020167005263A patent/KR20160041949A/ko not_active Ceased
-
2016
- 2016-01-29 MX MX2020011880A patent/MX2020011880A/es unknown
-
2018
- 2018-08-01 JP JP2018145202A patent/JP6639587B2/ja active Active
- 2018-10-24 US US16/169,908 patent/US11084867B2/en active Active
-
2019
- 2019-07-11 AU AU2019204972A patent/AU2019204972B2/en active Active
- 2019-12-24 JP JP2019232193A patent/JP6891257B2/ja active Active
-
2021
- 2021-08-09 US US17/397,870 patent/US20220098281A1/en not_active Abandoned
- 2021-10-08 AU AU2021245202A patent/AU2021245202B2/en active Active
-
2024
- 2024-08-27 US US18/817,095 patent/US20250171522A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016527979A5 (enExample) | ||
| MX2025005489A (es) | Uso de lumateperona para el tratamiento del trastorno bipolar ii | |
| ZA202202361B (en) | Treatment of hidradenitis suppurativa using jak inhibitors | |
| WO2010011526A3 (en) | Drug depots having one or more anchoring members | |
| RU2016104618A (ru) | Регенерация поврежденной ткани | |
| PH12012500968A1 (en) | Use of prostaglandins f2alpha and analogues for the healing of corneal and conjunctival lesions | |
| MX2021004546A (es) | Composiciones de suministro de farmaco implantables y metodos de uso de las mismas. | |
| WO2018102687A3 (en) | Combination therapy for treating cancer | |
| WO2017164609A3 (ko) | 피부 재생 또는 상처 치료용 펩타이드 및 이의 용도 | |
| MX2009012742A (es) | Ingrediente activo novedoso en cicatrizacion y uso del mismo. | |
| WO2009016629A3 (en) | Pharmaceutical composition for treating wounds and related methods | |
| PH12020550722A1 (en) | Ophthalmic topical composition comprising dobesilic acid for treating diseases of the posterior segment of the eye | |
| KR101612463B1 (ko) | 각질연화용 패치 | |
| CA3054005C (en) | Antiseptic composition comprising unithiol and dimethylsulfoxide, use of the composition and method of wound treatment with its use | |
| IS6555A (is) | Meðferð með aðskildum skömmtum sem hafa æðaskaðandi virkni | |
| WO2009004282A3 (en) | Medical dressing | |
| EP4257128A3 (en) | Methods and compounds for the treatment of genetic disease | |
| Willenborg et al. | 505 Fibroblast-derived TGF-beta1 regulates skin repair and fibrosis | |
| Linares et al. | 502 Cross-linked fibrin fragment (X-FIB) as a biomarker for endotype differentiation and response to omalizumab treatment in chronic spontaneous urticaria | |
| Auer et al. | 500 The urokinase inhibitor BC-11 attenuates skin fibrosis via macrophage-fibroblast crosstalk modulation | |
| Maschalidi et al. | 501 Boosting efferocytosis and messages from inflammatory death aid in tissue recovery and wound healing. | |
| Altinova et al. | 504 Hair follicle transplantation for hard to heal wounds: In vivo reflectance confocal microscopy asessment of skin regeneration | |
| RU2019129157A (ru) | Способ лечения гнойных и ожоговых ран раствором "ронколейкина" | |
| Saraswathy et al. | Patterned wound healing effect of topical recombinant human epidermal growth factor in trophic ulcers secondary to leprosy | |
| RU2524191C1 (ru) | Способ изготовления дренажа для лечения гнойно-воспалительных заболеваний мягких тканей челюстно-лицевой области |